Melatonin reduces pancreatic tumor cell viability by altering mitochondrial physiology

Journal of Pineal Research

Volumn 50, Issue 3, 2011, Pages 250-260

  Gonzalez, Antonio ^a   Del Castillo Vaquero, Angel ^a   Miro Moran, Alvaro ^a   Tapia, Jose A ^a   Salido, Gines M ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Apoptosis; AR42J; Calcium; Caspase 3; Melatonin; Mitochondria

Indexed keywords

CALCIUM ION; CASPASE 3; EGTAZIC ACID; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FLAVINE ADENINE NUCLEOTIDE; LUZINDOLE; MELATONIN; THAPSIGARGIN;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CANCER CELL; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ASSAY; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PANCREAS TUMOR; POLYACRYLAMIDE GEL ELECTROPHORESIS; RAT; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CALCIUM; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; MELATONIN; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; RATS;

EID: 79952547344     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2010.00834.x     Document Type: Article

References (69)

1. REITER RJ, TAN DX, Fuentes-Broto L. Melatonin: a multitasking molecule. Prog Brain Res 2010; 181:127-151.
2. REITER RJ. Melatonin: the chemical expression of darkness. Mol Cell Endocrinol 1991; 79:C153-C158.
3. HUNT AE, AL-GHOUL WM, GILLETTE MU, DUBOCOVICH ML. Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock. Am J Physiol Cell Physiol 2001; 280:C110-C118.
4. MCARTHUR AJ, HUNT AE, GILLETTE MU. Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: activation of protein kinase C at dusk and dawn. Endocrinology 1997; 138:627-634. (Pubitemid 27110912)
5. KONTUREK SJ, KONTUREK PC, BRZOZOWSKA I et al. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT). J Physiol Pharmacol 2007; 58:381-405. (Pubitemid 47523085)
6. LAVOIE J, GAGNÉ AM, LAVOIE MP et al. Circadian variation in the electroretinogram and the presence of central melatonin. Doc Ophthalmol 2010; 120:265-272.
7. PAREDES SD, KORKMAZ A, MANCHESTER LC et al. Phytomelatonin: a review. J Exp Bot 2009; 60:57-69.
8. MÜHLBAUER E, GROSS E, LABUCAY K et al. Loss of melatonin signalling and its impact on circadian rhythms in mouse organs regulating blood glucose. Eur J Pharmacol 2009; 606:61-71.
9. DUBOCOVICH M, MARKOWSKA M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005; 27:101-110.
10. MARTÍNEZ-CAMPA C, GONZALEZ A, MEDIAVILLA MD et al. Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells. Br J Cancer 2009; 101:1613-1619.
11. STUMPF I, BAZWINSKY I, PESCHKE E. Modulation of the cGMP signaling pathway by melatonin in pancreatic beta-cells. J Pineal Res 2009; 46:140-147.
12. DEL CASTILLO-VAQUERO A, SALIDO GM, GONZALEZ A. Melatonin induces calcium release from CCK-8- and thapsigarginsensitive cytosolic stores in pancreatic AR42J cells. J Pineal Res 2010; 49:256-263.
13. RAMRACHEYA RD, MULLER DS, SQUIRES PE et al. Function and expression of melatonin receptors on human pancreatic islets. J Pineal Res 2008; 44:273-279. (Pubitemid 351392941)
14. CRISTOFANON S, UGUCCIONI F, CERELLA C et al. Intracellular prooxidant activity of melatonin induces a survival pathway involving NF-kappaB activation. Ann N Y Acad Sci 2009; 1171:472-478.
15. MESSNER J, GRAF J. Reactive oxygen species facilitate the insulin-dependent inhibition of glucagon-induced glucose production in the isolated perfused rat liver. Wien Med Wochenschr 2008; 158:570-574.
16. GONZALEZ A, GRANADOS MP, SALIDO GM, PARIENTE JA. Changes in mitochondrial activity evoked by cholecystokinin in isolated mouse pancreatic acinar cells. Cell Signal 2003; 15:1039-1048. (Pubitemid 37130162)
17. DENTON RM, MCCORMACK JG. On the role of the calcium transport cycle in heart and other mammalian mitochondria. FEBS Lett 1980; 199:1-8. (Pubitemid 11212456)
18. HAJNOCZKY G, ROBB-GASPERS LD, SEIT MB, THOMAS AP. Decoding of cytosolic calcium oscillations in the mitochondria. Cell 1995; 82:415-424.
19. DEMAUREX N, DISTELHORST C. Cell biology. Apoptosis-the calcium connection. Science 2003; 300:65-67.
20. 2+signalling between sarco-endoplasmic reticulum and mitochondria. J Physiol 2000; 529:69-81.
21. GREEN DR, REED JC. Mitochondria and apoptosis. Science 1998; 281:1309-1312. (Pubitemid 28406816)
22. PARADIES G, PETROSILLO G, PARADIES V et al. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 2010; 48:297-310.
23. WANG X. The expanding role of mitochondria in apoptosis. Genes Dev 2001; 15:2922-2933. (Pubitemid 33078942)
24. TAN DX, CHEN LD, POEGGETER B, MANCHESTER LC, REITER RJ. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; i: 57-60.
25. HARDELAND R, TAN DX, REITER RJ. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009; 47:109-126.
26. REITER RJ, PAREDES SD, MANCHESTER LC, TAN DX. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009; 44:175-200.
27. SHARMA S, RANA SV. Melatonin inhibits benzene-induced lipid peroxidation in rat liver. Arh Hig Rada Toksikol 2010; 61:11-18.
28. SÖNMEZ MF, NARIN F, BALCIOǦLU E. Melatonin and vitamin C attenuates alcohol-induced oxidative stress in aorta. Basic Clin Pharmacol Toxicol 2009; 105:410-415.
29. HIBAOUI Y, ROULET E, RUEGG UT. Melatonin prevents oxidative stress-mediated mitochondrial permeability transition and death in skeletal muscle cells. J Pineal Res 2009; 47:238-252.
30. SIDHU S, PANDHI P, MALHOTRA S et al. Melatonin treatment is beneficial in pancreatic repair process after experimental acute pancreatitis. Eur J Pharmacol 2010; 628:282-289.
31. DAS A, MCDOWELL M, PAVA MJ et al. The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors. J Pineal Res 2010; 48:157-169.
32. ESPINO J, BEJARANO I, REDONDO PC et al. Melatonin reduces apoptosis induced by calcium signaling in human leukocytes: evidence for the involvement of mitochondria and Bax activation. J Membr Biol 2010; 233:105-118.
33. ESPINO J, BEJARANO I, ORTIZ A et al. Melatonin as a potential tool against oxidative damage and apoptosis in ejaculated human spermatozoa. Fertil Steril 2010; 94:1915-1917.
34. HILL SM, FRASCH T, XIANG S et al. Molecular mechanisms of melatonin anticancer effects. Integr Cancer Ther 2009; 8:337-346.
35. MARTIN-RENEDO J, MAURIZ JL, JORQUERA F et al. Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J Pineal Res 2008; 45:532-540.
36. BEJARANO I, REDONDO PC, ESPINO J et al. Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells. J Pineal Res 2009; 46:392-400.
37. EUM WS, LI MZ, SIN GS et al. Desamethasone-induced differentiation of pancreatic AR42J cell involves p21 (wafl/cipl) and MAP kinase pathway. Exp Mol Med 2003; 35:379-384. (Pubitemid 37474470)
38. YU JH, LIM JW, KIM KH et al. NADPH oxidase and apoptosis in cerulein-stimulated pancreatic acinar AR42J cells. Free Radic Biol Med 2005; 39:590-602.
39. 2+indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260:3440-3450.
40. GONZALEZ A, SCHMID A, SALIDO GM et al. XOD-catalyzed ROS generation mobilizes calcium from intracellular stores in mouse pancreatic acinar cells. Cell Signal 2002; 14:153-159. (Pubitemid 34056588)
41. GONZÁLEZ-FERNÁNDEZ L, ORTEGA-FERRUSOLA C, MACIAS-GARCIA B et al. Identification of protein tyrosine phosphatases and dual-specificity phosphatases in mammalian spermatozoa and their role in sperm motility and protein tyrosine phosphorylation. Biol Reprod 2009; 80:1239-1252.
42. 2+signals in mouse pancreatic acinar cells. J Biol Chem 2000; 275:38680-38686.
43. OZDEMIR F, DENIZ O, KAYNAR K et al. The effects of melatonin on human hepatoma (Hep G2) cell line. Bratisl Lek Listy 2009; 110:276-279.
44. 2+release from INS1 insulinoma cells. J Pineal Res 2005; 39:316-323.
45. LANOIX D, OUELLETTE R, VAILLANCOURT C. Expression of melatoninergic receptors in human placental choriocarcinoma cell lines. Hum Reprod 2006; 21:1981-1989. (Pubitemid 44288070)
46. RADA JA, WIECHMANN AF. Melatonin receptors in chick ocular tissues: implications for a role of melatonin in ocular growth regulation. Invest Ophthalmol Vis Sci 2006; 47:25-33. (Pubitemid 46780791)
47. RICHTER HG, TORRES-FARFAN C, GARCIA-SESNICH J et al. Rhythmic expression of functional MT1 melatonin receptors in the rat adrenal gland. Endocrinology 2008; 149:995-1003. (Pubitemid 351397921)
48. GENADE S, GENIS A, YTREHUS K et al. Melatonin receptor-mediated protection against myocardial ischaemia/reperfusion injury: role of its anti-adrenergic actions. J Pineal Res 2008; 45:449-458.
49. 2+-ATPase. Proc Natl Acad Sci USA 1990; 87:2466-2470.
50. HOTH M, FANGER CM, LEWIS RS. Mitochondrial regulation of store-operated calcium signaling in T lymphocytes. J Cell Biol 1997; 137:633-648. (Pubitemid 27200666)
51. DUCHEN MR, BISCOE TJ. Mitochondrial function in type I cells isolated from rabbit arterial chemoreceptors. J Physiol 1992; 450:13-31.
52. 2+channels in endoplasmic reticulum stress and beta-cell death. Diabetes 2009; 58:422-432.
53. WANG X. The antiapoptotic activity of melatonin in neurodegenerative diseases. CNS Neurosci Ther. 2009; 15:345-357.
54. FAN LL, SUN GP, WEI W et al. Melatonin and doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines. World J Gastroenterol 2010; 16:1473-1481.
55. CHRISTOPHE J. Pancreatic tumoral cell line AR42J: an amphicrine model. Am J Physiol 1994; 266:G963-G971.
56. 2+transients in HT29 cells. J Biol Chem 1998; 273:34961-34969.
57. GONZALEZ A, GRANADOS MP, SALIDO GM, PARIENTE JA. H2O2-induced changes in mitochondrial activity in isolated mouse pancreatic acinar cells. Mol Cell Biochem 2005; 269:165-173. (Pubitemid 40287814)
58. 2+waves in cultured oligodendrocytes. J Biol Chem 1996; 271:33493-33501.
59. 2+in cell physiology and pathophysiology. Cell Calcium 2000; 28:339-348.
60. KAKKAR P, SINGH BK. Mitochondria: a hub of redox activities and cellular distress control. Mol Cell Biochem 2007; 305:235-253. (Pubitemid 47517185)
61. HEIKAL AA. Intracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anomalies. Biomark Med 2010; 4:241-263.
62. 2+]i in type I cells isolated from the rabbit carotid body. J Physiol 1992; 450:33-61.
63. CROMPTON M. Mitochondria and aging: a role for the permeability transition? Aging Cell 2004; 3:3-6.
64. HALESTRAP AP. Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans 2006; 34:232-237.
65. MÜHLBAUER E, PESCHKE E. Evidence for the expression of both the MT1- and in addition, the MT2-melatonin receptor, in the rat pancreas, islet and beta-cell. J Pineal Res 2007; 42:105-106. (Pubitemid 44924332)
66. STEBELOVÁ K, ANTTILA K, MÄNTTÄRI S et al. Immunohistochemical definition of MT(2) receptors and melatonin in the gastrointestinal tissues of rat. Acta Histochem 2010; 112:26-33.
67. BAZWINSKY-WUTSCHKE I, MÜHLBAUER E, WOLGAST S, PESCHKE E. Transcripts of calcium/calmodulin-dependent kinases are changed after forskolin- or IBMX-induced insulin secretion due to melatonin treatment of rat insulinoma beta-cells (INS-1). Horm Metab Res 2009; 41:805-813.
68. DAUCHY RT, BLASK DE, DAUCHY EM et al. Antineoplastic effects of melatonin on a rare malignancy of mesenchymal origin: melatonin receptor-mediated inhibition of signal transduction, linoleic acid metabolism and growth in tissue-isolated humanleiomyosarcoma xenografts. J Pineal Res 2009; 47:32-42.
69. PICINATO MC, HIRATA AE, CIPOLLA-NETO J et al. Activation of insulin and IGF-1 signaling pathways by melatonin through MT1 receptor in isolated rat pancreatic islets. J Pineal Res 2008; 44:88-94. (Pubitemid 350231100)